KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Average (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Equity Average for 10 consecutive years, with $233.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Average fell 71.67% year-over-year to $233.0 million, compared with a TTM value of $233.0 million through Sep 2025, down 71.67%, and an annual FY2024 reading of $692.2 million, up 46.46% over the prior year.
  • Equity Average was $233.0 million for Q3 2025 at Medpace Holdings, down from $383.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $925.5 million in Q4 2021 and bottomed at $233.0 million in Q3 2025.
  • Average Equity Average over 5 years is $600.6 million, with a median of $615.2 million recorded in 2024.
  • The sharpest move saw Equity Average surged 94.38% in 2024, then plummeted 71.67% in 2025.
  • Year by year, Equity Average stood at $925.5 million in 2021, then tumbled by 60.22% to $368.1 million in 2022, then surged by 39.88% to $514.9 million in 2023, then soared by 65.75% to $853.5 million in 2024, then tumbled by 72.7% to $233.0 million in 2025.
  • Business Quant data shows Equity Average for MEDP at $233.0 million in Q3 2025, $383.0 million in Q2 2025, and $709.6 million in Q1 2025.